Georgia A. McCann

1.2k total citations · 1 hit paper
37 papers, 897 citations indexed

About

Georgia A. McCann is a scholar working on Oncology, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Georgia A. McCann has authored 37 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Obstetrics and Gynecology and 11 papers in Surgery. Recurrent topics in Georgia A. McCann's work include Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Maternal and fetal healthcare (5 papers). Georgia A. McCann is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Maternal and fetal healthcare (5 papers). Georgia A. McCann collaborates with scholars based in United States, Hungary and Switzerland. Georgia A. McCann's co-authors include David E. Cohn, David M. O’Malley, Filipa Lynce, Bruce J. Dezube, Melinda L. Telli, Lee S. Schwartzberg, Corrine Zarwan, Patrick M. Dillon, John K. Erban and Antoinette R. Tan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and American Journal of Obstetrics and Gynecology.

In The Last Decade

Georgia A. McCann

35 papers receiving 885 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

2019 314 citations Georgia A. McCann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Georgia A. McCann United States	16	554	250	150	146	145	37	897
Marilena Di Napoli Italy	16	433 0.8×	331 1.3×	169 1.1×	140 1.0×	210 1.4×	64	1.0k
Domenico Sergi Italy	16	359 0.6×	178 0.7×	166 1.1×	77 0.5×	90 0.6×	54	796
Yoshimichi Tanaka Japan	16	269 0.5×	350 1.4×	87 0.6×	87 0.6×	198 1.4×	45	850
Darlene Gibbon United States	15	325 0.6×	375 1.5×	115 0.8×	53 0.4×	123 0.8×	38	834
Adam C. ElNaggar United States	13	238 0.4×	173 0.7×	91 0.6×	85 0.6×	76 0.5×	68	579
Tomohito Tanaka Japan	18	291 0.5×	348 1.4×	93 0.6×	97 0.7×	333 2.3×	81	1.0k
Shu Soeda Japan	14	205 0.4×	144 0.6×	84 0.6×	126 0.9×	180 1.2×	67	702
Lei Deng China	12	330 0.6×	219 0.9×	71 0.5×	278 1.9×	74 0.5×	25	786
Xi Cheng China	13	262 0.5×	251 1.0×	138 0.9×	71 0.5×	262 1.8×	30	923

Countries citing papers authored by Georgia A. McCann

Since Specialization

Citations

This map shows the geographic impact of Georgia A. McCann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgia A. McCann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgia A. McCann more than expected).

Fields of papers citing papers by Georgia A. McCann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgia A. McCann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgia A. McCann. The network helps show where Georgia A. McCann may publish in the future.

Co-authorship network of co-authors of Georgia A. McCann

This figure shows the co-authorship network connecting the top 25 collaborators of Georgia A. McCann. A scholar is included among the top collaborators of Georgia A. McCann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgia A. McCann. Georgia A. McCann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Munoz, Jessian L., et al.. (2024). Risk factors for intensive care unit admission after cesarean hysterectomy for placenta accreta spectrum. International Journal of Gynecology & Obstetrics. 167(2). 656–662. 2 indexed citations

Byrne, John J., et al.. (2024). Association between Antenatal Vaginal Bleeding and Adverse Perinatal Outcomes in Placenta Accreta Spectrum. Medicina. 60(4). 677–677.

Han, Chae Young, Karen H. Lu, Deepak G. Bedi, et al.. (2023). The Normal Risk Ovarian Screening Study (NROSS): Twenty-one year update.. Journal of Clinical Oncology. 41(16_suppl). 5522–5522. 2 indexed citations

Munoz, Jessian L., et al.. (2023). Risk factors of massive blood transfusion (MTP) in cesarean hysterectomy for placenta accreta spectrum. European Journal of Obstetrics & Gynecology and Reproductive Biology. 293. 32–35. 2 indexed citations

Braun, Andrew T., et al.. (2020). Immediate Repair of a Complete Uterine Transection After Motor Vehicle Collision. Obstetrics and Gynecology. 136(5). 950–952. 3 indexed citations

Backes, Floor, Margaret Liang, Georgia A. McCann, et al.. (2015). Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities. International Journal of Gynecological Cancer. 25(7). 1271–1276. 15 indexed citations

Rath, Kellie S., Shan K. Naidu, Hemant K. Bid, et al.. (2014). HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer. Cancer Research. 74(8). 2316–2327. 76 indexed citations

McCann, Georgia A. & Eric Eisenhauer. (2014). Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: Surgical options for personalized care. Journal of Surgical Oncology. 111(1). 118–124. 13 indexed citations

Chao, Albert H., Georgia A. McCann, & Jeffrey M. Fowler. (2014). Bilateral groin reconstruction with a single anterolateral thigh perforator flap as an alternative to traditional myocutaneous flaps. PubMed. 9. 15–17. 5 indexed citations

10.

Tierney, Brent J., Georgia A. McCann, Shan K. Naidu, et al.. (2014). Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor. Gynecologic Oncology. 135(1). 133–141. 18 indexed citations

11.

Neff, Robert, Georgia A. McCann, Kristen M. Carpenter, et al.. (2014). Is bariatric surgery an option for women with gynecologic cancer? Examining weight loss counseling practices and training among gynecologic oncology providers. Gynecologic Oncology. 134(3). 540–545. 22 indexed citations

12.

Liang, Margaret, Georgia A. McCann, Kellie S. Rath, et al.. (2014). Training the Next Generation of Robotic Surgeons Using Guided Mentorship: A Randomized Controlled Trial. Journal of Minimally Invasive Gynecology. 21(6). 1075–1079. 9 indexed citations

13.

McCann, Georgia A., Floor Backes, Eric Eisenhauer, et al.. (2013). Neuroendocrine carcinoma of the uterine cervix: The role of multimodality therapy in early-stage disease. Gynecologic Oncology. 129(1). 135–139. 25 indexed citations

14.

Rath, Kellie S., Georgia A. McCann, David E. Cohn, et al.. (2013). Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs. Journal of Ovarian Research. 6(1). 35–35. 24 indexed citations

15.

Backes, Floor, Debra L. Richardson, Georgia A. McCann, et al.. (2013). Should Bevacizumab Be Continued After Progression on Bevacizumab in Recurrent Ovarian Cancer?. International Journal of Gynecological Cancer. 23(5). 833–838. 9 indexed citations

16.

McCann, Georgia A., et al.. (2012). Abstract 2802: Selective inhibition of signal transducers and activators of transcription 3 overexpressing endometrial cancer cells, using HO-3867, a novel STAT3 inhibitor. Cancer Research. 72(8_Supplement). 2802–2802. 3 indexed citations

17.

Backes, Floor, D. Richardson, Georgia A. McCann, et al.. (2012). Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?. Gynecologic Oncology. 125. S94–S94. 1 indexed citations

18.

McCann, Georgia A., Gary Phillips, Eric Eisenhauer, et al.. (2012). The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer. Gynecologic Oncology. 128(1). 44–48. 35 indexed citations

19.

Tierney, Brent J., Georgia A. McCann, David E. Cohn, et al.. (2012). HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells. Cancer Biology & Therapy. 13(9). 766–775. 34 indexed citations

20.

O’Malley, David M., Debra L. Richardson, Ritu Salani, et al.. (2011). Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer. Gynecologic Oncology. 121(2). 269–272. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact